Verrica Pharmaceuticals Inc.
NASDAQ: VRCA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jayson Rieger
- Employees
- 76
- Headquarters
- West Chester, United States
- IPO year
- 2018
- Market cap
- $62.3M
- Website
- https://www.verrica.com
Loading VRCA…
Loading profile data…Frequently asked questions about VRCA
What does Verrica Pharmaceuticals Inc. (VRCA) do?
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in...
Where does VRCA trade?
Verrica Pharmaceuticals Inc. (VRCA) trades on the NASDAQ.
What sector is VRCA in?
Verrica Pharmaceuticals Inc. (VRCA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Verrica Pharmaceuticals Inc.?
Jayson Rieger is the chief executive officer of Verrica Pharmaceuticals Inc. (VRCA).
Where is Verrica Pharmaceuticals Inc. headquartered?
Verrica Pharmaceuticals Inc. is headquartered in United States.
Does VRCA pay a dividend?
Verrica Pharmaceuticals Inc. (VRCA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VRCA go public?
Verrica Pharmaceuticals Inc. (VRCA) completed its initial public offering in 2018.